How big is the Virology Market | Trends, Growth Drivers & Forecast 2025

Code: MTA9466 Publication Date: Sep 2025

What is the size of Virology Market?

According to 6Wresearch internal database and industry insights, the Global Virology Market was valued at USD 3.4 Billion in 2024 and is expected to reach USD 5.2 Billion by 2031, growing at a compound annual growth rate of 6.20% during the forecast period (2025-2031).

The principal factors contributing to this growth in the Virology Market are the increasing occurrence of viral infections, rising investments in vaccines and antiviral therapies, and improvements in laboratory testing technology and molecular diagnostics. 

Growth Factors for Virology Market

  • The increasing prevalence of viral diseases is driving demand for virology testing and research. 
  • Rising investments in vaccine development can support the growth of the market.
  • Advancements in molecular diagnostics and PCR testing allow for improvements in detection rates. 
  • Rapidly rising biotechnology and pharmaceutical research and development R and D is encouraging antiviral therapy innovations.
  • Increasing use of cell culture and immunological assays is promoting laboratory research. 

Virology Market Trends

The trends within the virology market are increasing focus on molecular diagnostic tools, next-generation sequencing to advance both detection and surveillance of viral infections. Companies are concluding executive focus on several initiatives, including vaccine development, antiviral drug discovery, and immunotherapy domains for R and D. There is also increasing laboratory automation and digitization that enhances testing outcome efficiencies. Additionally, there are growing collaborations of academic institutions and research organizations with pharmaceutical companies, widening the capabilities of preventive and therapeutic virology solutions.

Emerging Developments in the Virology Market

The virology market developments highlight innovations in vaccine platforms, antiviral drug formulations, and diagnostic technologies. Increasing adoption of point-of-care molecular tests is enhancing early detection. Biotechnology firms are investing in monoclonal antibody therapies and RNA-based treatments. Strategic collaborations between research institutes and pharmaceutical companies are accelerating clinical development. Furthermore, advances in bioinformatics and virology-focused AI applications are supporting predictive modeling and drug discovery efforts.

List of Leading Companies in the Virology Market

Some of the leading companies include:

  • Abbott Laboratories
  • F. Hoffmann-La Roche Ltd.
  • Thermo Fisher Scientific Inc.
  • QIAGEN N.V.
  • Merck KGaA
  • Bio-Rad Laboratories, Inc.
  • Gilead Sciences, Inc.

Frequently Asked Questions About the Market Study (FAQs):

6W monitors the market across 60+ countries Globally, publishing an annual market outlook report that analyses trends, key drivers, Size, Volume, Revenue, opportunities, and market segments. This report offers comprehensive insights, helping businesses understand market dynamics and make informed decisions.
Yes, we provide customisation as per your requirements. To learn more, feel free to contact us on sales@6wresearch.com
6Wresearch Support

Any Query

Call: +91-11-4302-4305
Email us: sales@6wresearch.com
Any Query? Click Here

Industry Events and Analyst Meet

Our Clients

Airtel
Canon
Contec
HoneyWell
Kriloskar
Pwc Logo
Samsung
Tata Teleservices

Whitepaper

Read All